Dick E. de Vries

Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Multiple Intravenous, Dose‐Ascending Study of Sirukumab in Cutaneous or Systemic Lupus Erythematosus

Jacek C. Szepietowski, Surasak Nilganuwong, Anna Woźniacka et al. · Arthritis & Rheumatism · 2013 · 112 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Golimumab Pharmacokinetics After Repeated Subcutaneous and Intravenous Administrations in Patients with Rheumatoid Arthritis and the Effect of Concomitant Methotrexate: An Open-Label, Randomized Study

Yanli Zhuang, Zhenhua Xu, Bart Frederick et al. · Clinical Therapeutics · 2011 · 92 citations

Medicine, Pharmacokinetics, Pharmacology +12

Evaluation of disease‐mediated therapeutic protein–drug interactions between an anti–interleukin‐6 monoclonal antibody (sirukumab) and cytochrome P450 activities in a phase 1 study in patients with rheumatoid arthritis using a cocktail approach

Yanli Zhuang, Dick E. de Vries, Zhenhua Xu et al. · The Journal of Clinical Pharmacology · 2015 · 80 citations

Medicine, Pharmacokinetics, Pharmacology +17

Photoprovocation in Cutaneous Lupus Erythematosus: A Multicenter Study Evaluating a Standardized Protocol

Annegret Kuhn, Anna Woźniacka, Jacek C. Szepietowski et al. · Journal of Investigative Dermatology · 2011 · 56 citations · Full text

Medicine, Dermatology, Immunology +12

MANTA and MANTA-RAy: Rationale and Design of Trials Evaluating Effects of Filgotinib on Semen Parameters in Patients with Inflammatory Diseases

Wayne J.G. Hellstrom, Radboud J. E. M. Dolhain, Timothy E. Ritter et al. · Advances in Therapy · 2022 · 37 citations · Full text

Medicine, Immunology, Pharmacotherapy +17